series-c-plus
Stage
1
Investors
About
Atelerix develops hypothermic hydrogel technology that enables the storage and transport of biological samples such as cells, tissues, and viruses at ambient temperatures, eliminating the need for cryopreservation and reducing costs and logistical complexities.
Explore Atelerix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.